Furthermore, we discovered that inhibiting NSUN2 heightened the sensitivity of NSCLC cells to both erastin and RSL3-induced ferroptosis, a shift mediated by the downregulation of NRF2 protein expression. The gene discussed is NSUN2; the disease is non-small cell lung carcinoma.